NYSE: CRD.ACrawford & Co Stock
$11.59+0.09 (+0.78%)
Updated Jan 14, 2025
CRD.A Price
$11.59
Fair Value Price
N/A
Market Cap
$568.03M
52 Week Low
$7.55
52 Week High
$13.61
P/E
28.27x
P/B
3.53x
P/S
0.41x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.30B
Earnings
$20.06M
Gross Margin
27.9%
Operating Margin
3.61%
Profit Margin
1.5%
Debt to Equity
3.99
Operating Cash Flow
$47M
Beta
0.82
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CRD.A Overview
Crawford & Company provides claims and outsourcing solutions to risk management, insurance, and self-insuring entities in the U.S. and internationally. Among its segments are Crawford Claims Solutions, which serves property and casualty insurance companies, and Crawford TPA Solutions, which provides third-party administration of workers' compensation, auto and liability claims, disability absence management, medical claims management, and accident and health claims management to corporations, brokers, and insurers. The company was founded in 1941 and is headquartered in Atlanta, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CRD.A's potential to beat the market
AStrong Buy
- Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More
Zen Rating Component Grades
B
Value
C
Growth
C
Momentum
C
Sentiment
B
Safety
B
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Insurance
Industry Rating
C
CRD.A
Ranked#1 of 16
Ranked#1 of 16
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $399.78 | B | |
| $110.18 | B | |
| $1.51 | C |
Be the first to know about important CRD.A news, forecast changes, insider trades & much more!
CRD.A News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CRD.A scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CRD.A was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CRD.A is good value based on its earnings relative to its share price (28.27x), compared to the US market average (30.21x)
P/E vs Market Valuation
CRD.A is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CRD.A due diligence checks available for Premium users.
Valuation
CRD.A price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.27x
Industry
25.77x
Market
30.21x
CRD.A is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CRD.A is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CRD.A price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.53x
Industry
6.68x
CRD.A is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CRD.A's financial health
Profit margin
Revenue
$342.7M
Net Income
$9.5M
Profit Margin
2.8%
CRD.A's Earnings (EBIT) of $47.07M... subscribe to Premium to read more.
Interest Coverage Financials
CRD.A's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$800.8M
Liabilities
$641.6M
Debt to equity
3.99
CRD.A's short-term assets ($362.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRD.A's short-term assets ($362.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRD.A's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CRD.A's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$19.3M
Investing
-$11.0M
Financing
-$2.3M
CRD.A's operating cash flow ($46.81M)... subscribe to Premium to read more.
Debt Coverage Financials
CRD.A vs Insurance Stocks
Crawford & Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.